Edgen Stock·Oct 06 2025, 11:56戻る
戻る
ACADIA Pharmaceuticals Navigates Pipeline Setback Amidst Commercial Strength
Edgen Stock·Oct 06 2025, 11:56
[1] ACADIA Pharmaceuticals: Nuplazid And Daybue Are Enough To Remain Bullish (ACAD) | Seeking Alpha[2] Shareholder Risk and Corporate Governance at ACADIA Pharmaceuticals: Legal Scrutiny and Investor Confidence in the Wake of ACP-101's Failure - AInvest[3] Acadia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operating Overview